0001209191-14-014628.txt : 20140226
0001209191-14-014628.hdr.sgml : 20140226
20140226200401
ACCESSION NUMBER: 0001209191-14-014628
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140224
FILED AS OF DATE: 20140226
DATE AS OF CHANGE: 20140226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10165 MCKELLAR CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TAMERIUS JOHN
CENTRAL INDEX KEY: 0001222788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 14646402
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-02-24
0
0000353569
QUIDEL CORP /DE/
QDEL
0001222788
TAMERIUS JOHN
10165 MCKELLAR COURT
SAN DIEGO
CA
92121
0
1
0
0
SVP - Clinical/Reg Affairs
Common Stock
2014-02-25
4
S
0
24464
27.566
D
32019
D
Common Stock
2014-02-26
4
M
0
8891
12.63
A
40910
D
Common Stock
2014-02-26
4
M
0
13891
15.28
A
54801
D
Common Stock
2014-02-26
4
S
0
22782
27.8187
D
32019
D
Non-Qualified Stock Options
27.57
2014-02-24
4
A
0
21068
0.00
A
2024-02-24
Common Stock
21068
21068
D
Restricted Stock Units
2014-02-24
4
A
0
961
0.00
A
Common Stock
961
961
D
Non-Qualified Stock Options
12.63
2014-02-26
4
M
0
8891
0.00
D
2013-03-02
2021-03-02
Common Stock
8891
16109
D
Non-Qualified Stock Options
15.28
2014-02-26
4
M
0
13891
0.00
D
2014-01-18
2020-01-18
Common Stock
13891
4630
D
The weighted average sale price for these transactions was $27.566 per share, with a range of $27.69 to $27.50 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $27.8187 per share, with a range of $27.72 to $27.97 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
10,534 shares will vest on the second anniversary date of the grant date, February 24, 2016. 5,267 shares will vest on the third anniversary date of the grant date, February 24, 2017. 5,267 shares will vest on the fourth anniversary date of the grant date, February 24, 2018.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
480 shares will vest on the second anniversary date of the grant date, February 24, 2016. 240 shares will vest on the third anniversary date of the grant date, February 24, 2017. 241 shares will vest on the fourth anniversary date of the grant date, February 24, 2018.
Robert J. Bujarski, attorney-in-fact for John Tamerius
2014-02-26